Assessment of Esophageal Motility in Patients With Eosinophilic Esophagitis: A Scoping Review.
Journal
Journal of clinical gastroenterology
ISSN: 1539-2031
Titre abrégé: J Clin Gastroenterol
Pays: United States
ID NLM: 7910017
Informations de publication
Date de publication:
01 Jan 2023
01 Jan 2023
Historique:
received:
24
05
2022
accepted:
08
10
2022
entrez:
12
12
2022
pubmed:
13
12
2022
medline:
15
12
2022
Statut:
epublish
Résumé
Eosinophilic esophagitis (EoE) is a chronic, immune-mediated condition causing esophageal symptoms, particularly dysphagia. Despite the important progress in the treatment of EoE, a significant proportion of patients continue to report symptoms that negatively impact quality of life. Esophageal manometry is used to assess motility and function, but is not routinely used in EoE. We aimed to systematically review and describe current literature evaluating esophageal manometry in EoE. Forty-eight studies meeting the criteria were identified, describing 802 patients. Using standard water swallow protocols, the proportion of abnormalities detected was not dissimilar to other populations, apart from disorders of esophago-gastric outflow, which were found in 5%. Twelve studies described pretreatment and posttreatment manometry, with motility normalization after pharmacological therapy reported in 20%. Early, brief panesophageal pressurization was described in a number of studies and was more prevalent in the few studies utilizing additional provocation testing. Reports in the literature regarding temporal relationships between manometric findings and symptoms are variable. Esophageal manometry may be capable of detecting clinically relevant changes to esophageal function in EoE. Possible mechanisms are altered neuromuscular function because of secretory products of EoE and/or fibroinflammatory processes, manifesting as pressurization because of altered esophageal compliance. Some changes may be reversible with therapy. Drawing strong conclusions from the literature is difficult, with bias toward case reports and retrospective observation. Adaptations to assessment protocols to include provocation testing may provide more robust evaluation and detect clinically relevant, subtle changes in esophageal function, earlier within the patient pathway.
Identifiants
pubmed: 36504227
doi: 10.1097/MCG.0000000000001792
pii: 00004836-202301000-00003
doi:
Types de publication
Review
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
10-30Informations de copyright
Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc.
Références
Koutlas NT, Dellon ES. Progression from an inflammatory to a fibrostenotic phenotype in eosinophilic esophagitis. Case Rep Gastroenterol. 2017;11:382–388.
Molina-Infante J, Rivas MD, Hernandez-Alonso M, et al. Proton pump inhibitor-responsive oesophageal eosinophilia correlates with downregulation of eotaxin-3 and Th2 cytokines overexpression. Aliment Pharmacol Ther. 2014;40:955–965.
Lucendo AJ, Arias Á, Molina-Infante J. Efficacy of proton pump inhibitor drugs for inducing clinical and histologic remission in patients with symptomatic esophageal eosinophilia: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2016;14:13–22.e1.
Laserna-Mendieta EJ, Casabona S, Guagnozzi D, et al. Efficacy of proton pump inhibitor therapy for eosinophilic oesophagitis in 630 patients: results from the EoE connect registry. Aliment Pharmacol Ther. 2020;52:798–807.
Tomizawa Y, Melek J, Komaki Y, et al. Efficacy of pharmacologic therapy for eosinophilic esophagitis a systematic review and network meta-analysis. J Clin Gastroenterol. 2018;52:596–606.
Lucendo AJ, Miehlke S, Schlag C, et al. Efficacy of budesonide orodispersible tablets as induction therapy for eosinophilic esophagitis in a randomized placebo-controlled trial. Gastroenterology. 2019;157:74–86.e15.
Straumann A, Lucendo AJ, Miehlke S, et al. Budesonide orodispersible tablets maintain remission in a randomized, placebo-controlled trial of patients with eosinophilic esophagitis. Gastroenterology. 2020;159:1672–1685.e5.
De Heer J, Miehlke S, Rösch T, et al. Histologic and clinical effects of different topical corticosteroids for eosinophilic esophagitis: lessons from an updated meta-analysis of placebo-controlled randomized trials. Digestion. 2021;102:377–385.
Miehlke S, Lucendo AJ, Straumann A, et al. Orodispersible budesonide tablets for the treatment of eosinophilic esophagitis: a review of the latest evidence. Therap Adv Gastroenterol. 2020;13:1–15.
Pokrzywinski RM, Harding G, Brooks A, et al. Documenting the journey of patients with eosinophilic esophagitis and the impact of the disease on patients and their caregivers: a cross-sectional, qualitative research study. Adv Ther. 2020;37:4458–4478.
Fox MR, Kahrilas PJ, Roman S, et al. Clinical measurement of gastrointestinal motility and function: who, when and which test. Nat Rev Gastroenterol Hepatol. 2018;15:568–579.
Kahrilas PJ, Ghosh SK, Pandolfino JE. Esophageal motility disorders in terms of pressure topography. J Clin Gastroenterol. 2008;42:627–635.
Bredenoord AJ, Fox M, Kahrilas PJ, et al. Chicago classification criteria of esophageal motility disorders defined in high resolution esophageal pressure topography1. Neurogastroenterol Motil. 2012;24:57–65.
Kahrilas PJ, Bredenoord AJ, Fox M, et al. The Chicago classification of esophageal motility disorders, v3.0. Neurogastroenterol Motil. 2015;27:160–174.
Yadlapati R, Kahrilas PJ, Fox MR, et al. Esophageal motility disorders on high‐resolution manometry: Chicago classification version 4.0 ©. Neurogastroenterol Motil. 2021;33:1–21. doi:10.1111/nmo.14058
doi: 10.1111/nmo.14058
Tricco AC, Lillie E, Zarin W, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169:467–473.
Sato H, Takeuchi M, Takahashi K. Eosinophilic infiltration of the muscularis propria in a patient with jackhammer esophagus treated with per-oral endoscopic myotomy. Clin Gastroenterol Hepatol. 2015;13:e33–e34.
Dellon ES, Gonsalves N, Rothenberg ME, et al. Determination of biopsy yield that optimally detects eosinophilic gastritis and/or duodenitis in a randomized trial of lirentelimab. Clin Gastroenterol Hepatol. 2022;20:535–545.e15.
Spechler SJ. Classification of oesophageal motility abnormalities. Gut. 2001;49:145–151.
Clouse RE, Staiano A, Alrakawi A, et al. Application of topographical methods to clinical esophageal manometry. Am J Gastroenterol. 2000;95:2720–2730.
Feczko PJ, Halpert RD, Zonca M. Radiographic abnormalities in eosinophilic esophagitis. Gastrointest Radiol. 1985;10:321–324.
Tanaka S, Toyonaga T, Kawara F, et al. A case of jackhammer esophagus caused by eosinophilic esophagitis in which per-oral endoscopic myotomy resulted in symptom improvement. Clin J Gastroenterol. 2018;11:377–381.
Savarino E, Gemignani L, Zentilin P, et al. Achalasia with dense eosinophilic infiltrate responds to steroid therapy. Clin Gastroenterol Hepatol. 2011;9:1104–1106.
Cantu P, Velio P, Penagini R, et al. Ringed oesophagus and idiopathic eosinophilic oesophagitis in adults: an association in two cases. Dig Liver Dis, 37:129–134.
Funaki Y, Ogasawara N, Kawamura Y, et al. Markedly effective steroid treatment of three patients with allergy-related jackhammer esophagus. Intern Med. 2020;59:633–639.
Snyder D, Gonzalez Y, Venu M. A case of eosinophilic esophagitis with achalasia requiring myotomy. Am J Gastroenterol. 2014;109:S236.
Frieling T, Heise J, Kreysel C, et al. Eosinophilic esophagitis and achalasia: just a coincidence? Z Gastroenterol. 2019;57:151–155.
Louis-Auguste JR, Hoare J. A hard act to swallow: modern management of eosinophilic oesophagitis. Frontline Gastroenterol. 2013;4:91–95.
Furuta K, Adachi K, Kowari K, et al. A Japanese case of eosinophilic esophagitis. J Gastroenterol. 2006;41:706–710.
Hempel SL, Elliott DE. Chest pain in an aspirin-sensitive asthmatic patient. Chest. 1996;110:1117–1120.
Straumann A, Rossi L, Simon HU, et al. Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis. Gastrointest Endosc. 2003;57:407–412.
Engel MA, Raithel M, Amann K, et al. Rare coincidence of eosinophilic esophagitis with esophageal stenosis and intramural pseudodiverticulosis. Dig Liver Dis. 2008;40:700–706.
Auron M, Whinney C, Shay S, et al. Refractory eosinophilic esophagitis and severe GERD: an unfortunate combination. J Hosp Med. 2012;7:1.
Düsünür Günşen F, Sin AZ, Peker Koc Z, et al. A case of eosinophilic esophagitis with allergic rhinitis. Allergy Eur J Allergy Clin Immunol. 2016;71:481.
Harriss PB, Roussel J, Chiu YT, et al. 3092 a clinically confounding presentation of dysphagia with multiple valid etiologies. Am J Gastroenterol. 2019;114:S1661–S1662.
Vidyaeva N, Kashin S, Kaybysheva V, et al. A case of eosinophilic esophagitis: heartburn does not always mean gastroesophageal reflux disease. Endoscopy. 2019;51:S243.
Attwood SEA, Smyrk TC, Demeester TR, et al. Esophageal eosinophilia with dysphagia. Dig Dis Sci. 1993;38:109–116.
Vasilopoulos S, Murphy P, Auerbach A, et al. The small-caliber esophagus: An unappreciated cause of dysphagia for solids in patients with eosinophilic esophagitis. Gastrointest Endosc. 2002;55:99–106.
Croese J, Fairley SK, Masson JW, et al. Clinical and endoscopic features of eosinophilic esophagitis in adults. Gastrointest Endosc. 2003;58:516–522.
Gonsalves N, Policarpio-Nicolas M, Zhang Q, et al. Histopathologic variability and endoscopic correlates in adults with eosinophilic esophagitis. Gastrointest Endosc. 2006;64:313–319.
Remedios M, Campbell C, Jones DM, et al. Eosinophilic esophagitis in adults: clinical, endoscopic, histologic findings, and response to treatment with fluticasone propionate. Gastrointest Endosc. 2006;63:3–12.
Lucendo A, Pascual-Turrión J, Navarro M, et al. Endoscopic, bioptic, and manometric findings in eosinophilic esophagitis before and after steroid therapy: a case series. Endoscopy. 2007;39:765–771.
Rodrigo S, Abboud G, Oh D, et al. High intraepithelial eosinophil counts in esophageal squamous epithelium are not specific for eosinophilic esophagitis in adults. Am J Gastroenterol. 2008;103:435–442.
Alexandropoulou K, Ramakrishnan R, Chong H, et al. Eosinophilic oesophagitis: gastro-oesophageal reflux disease interface. Abstr Gut. 2009;58:A140.
Bassett J, Maydonovitch C, Perry J, et al. Prevalence of esophageal dysmotility in a cohort of patients with esophageal biopsies consistent with eosinophilic esophagitis. Dis esophagus Off J Int Soc Dis Esophagus. 2009;22:543–548.
Hejazi RA, Reddymasu SC, Sostarich S, et al. Disturbances of esophageal motility in eosinophilic esophagitis: a case series. Dysphagia. 2010;25:231–237.
Fox MR, Sauter M, Heinrich H, et al. The cause of dysphagia in eosinophilic oesophagitis: obstruction to bolus passage not oesophageal dysmotility. Gut. 2011;60(suppl 1):A173–A174.
García-Compeán D, González González JA, Marrufo García CA, et al. Prevalence of eosinophilic esophagitis in patients with refractory gastroesophageal reflux disease symptoms: a prospective study. Dig Liver Dis. 2011;43:204–208.
Martín Martín L, Santander C, Lopez Martín MC, et al. Esophageal motor abnormalities in eosinophilic esophagitis identified by high-resolution manometry. J Gastroenterol Hepatol. 2011;26:1447–1450.
Moawad FJ, Maydonovitch CL, Veerappan GR, et al. Esophageal motor disorders in adults with eosinophilic esophagitis. Dig Dis Sci. 2011;56:1427–1431.
Roman S, Hirano I, Kwiatek MA, et al. Manometric features of eosinophilic esophagitis in esophageal pressure topography. Neurogastroenterol Motil. 2011;23:208–e111.
Monnerat MMC, Lemme EMdeO. Eosinophilic esophagitis: manometric and pHmetric findings. Arq Gastroenterol. 2012;49:113–117.
Rameshshanker R, Patel P, Moorghen M, et al. PWE-180 Clinical and laboratory characteristics and the use of biodegradable stents in eosinophilic oesophagitis: a single centre UK experience. Gut. 2012;61(Suppl 2):A369.2–A370.
Carcamo-Molina D, Nguyen S, Snape WJ, et al. Esophageal peristalsis and motility in patients with eosinophilic esophagitis. Neurogastroenterol Motil. 2013;25:29–30.
Weigt J, Kandulski A, Malfertheiner P, et al. Su1896 eosinophilic esophagitis in adults : association with esophageal motor dysfunction? Gastroenterology. 2013;144:S–503.
van Rhijn BD, Oors JM, Smout AJPM, et al. Prevalence of esophageal motility abnormalities increases with longer disease duration in adult patients with eosinophilic esophagitis. Neurogastroenterol Motil. 2014;26:1349–1355.
Colizzo JM, Clayton SB, Richter JE. Intrabolus pressure on high-resolution manometry distinguishes fibrostenotic and inflammatory phenotypes of eosinophilic esophagitis. Dis Esophagus. 2016;29:551–557.
Nennstiel S, Bajbouj M, Becker V, et al. High-resolution manometry in patients with eosinophilic esophagitis under topical steroid therapy-a prospective observational study (HIMEOS-study. Neurogastroenterol Motil. 2016;28:599–607.
Sato H, Nakajima N, Takahashi K, et al. Proposed criteria to differentiate heterogeneous eosinophilic gastrointestinal disorders of the esophagus, including eosinophilic esophageal myositis. World J Gastroenterol. 2017;23:2414.
von Arnim U, Kandulski A, Weigt J, et al. Correlation of high-resolution manometric findings with symptoms of dysphagia and endoscopic features in adults with eosinophilic esophagitis. Dig Dis. 2017;35:472–477.
Della Coletta M, De Bortoli N, Bartolo O, et al. P.06.2 Proton pump inhibitor therapy improves esophageal symptoms by restoring a normal esophageal peristalsis in PPI-REE. Dig Liver Dis. 2018;50:e179.
Colizzo J, Clayton S, Kumar A, et al. Intrabolus pressure has better correlation than eosinophilia with dysphagia severity in fibrostenotic eosinophilic esophagitis: a pilot study. Gastrointest Disord. 2018;1:3–14.
Hosaka H, Kuribayashi S, Shimoyama Y, et al. PS01.016: esophageal dysmotility caused by esophageal eosinophilia regulates patients’ symptoms and treatment requirements. Dis Esophagus. 2018;31(suppl 1):54–55.
Manu K, Aceves SS, Valasek MA, et al. Sa1135: baseline impedance on high-resolution impedance manometry correlates with severity of eosinophilic esophagitis endoscopic reference score. Gastroenterology. 2018;154:S–253.
Wong S, Tippett MD, Safaeian R, et al. Mo1138: a comprehensive assessment of eosinophilic oesophagitis using high-resolution manometry, mucosal biopsy and endoscopic ultrasound in adults. Gastroenterology. 2019;156:S–719.
Ghisa M, Laserra G, Marabotto E, et al. Achalasia and obstructive motor disorders are not uncommon in patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2021;19:1554–1563.
Muroi K, Kakushima N, Furukawa K, et al. Subjective symptoms in patients with eosinophilic esophagitis are related to esophageal wall thickness and esophageal body pressure. Dig Dis Sci. 2020;158:S–826.
Rettura F, Savarino EV, Frazzoni M, et al. T01.02.10 provocative tests during high-resolution manometry may be helpful to distinguish patients with eosinophilic esophagitis responding to PPI therapy. Dig Liver Dis. 2020;52:S66–S67.
Lucendo AJ, Molina-Infante J, Arias Á, et al. Guidelines on eosinophilic esophagitis: evidence-based statements and recommendations for diagnosis and management in children and adults. United Eur Gastroenterol J. 2017;5:335–358.
Dhar A, Haboubi HN, Attwood SE, et al. British Society of Gastroenterology (BSG) and British Society of Paediatric Gastroenterology, Hepatology and Nutrition (BSPGHAN) joint consensus guidelines on the diagnosis and management of eosinophilic oesophagitis in children and adults. Gut. 2022;71:1459–1487.
Hollenstein M, Thwaites P, Bütikofer S, et al. Pharyngeal swallowing and oesophageal motility during a solid meal test: a prospective study in healthy volunteers and patients with major motility disorders. Lancet Gastroenterol Hepatol. 2017;2:644–653.
Lin Z, Kahrilas PJ, Roman S, et al. Refining the criterion for an abnormal integrated relaxation pressure in esophageal pressure topography based on the pattern of esophageal contractility using a classification and regression tree model. Neurogastroenterol Motil. 2012;24:e356–e363.
Ang D, Misselwitz B, Hollenstein M, et al. Diagnostic yield of high-resolution manometry with a solid test meal for clinically relevant, symptomatic oesophageal motility disorders: serial diagnostic study. Lancet Gastroenterol Hepatol. 2017;2:654–661.
Alani M, Al-Jashaami L, Mills M, et al. Prevalence of esophageal motility disorders in an open access hybrid “academic - community setting” patient population. Am J Gastroenterol. 2018;113(suppl):S180–S181.
Pandolfino JE, Ghosh SK, Rice J, et al. Classifying esophageal mtility by pressure topography characteristics: a study of 400 patients and 75 controls. Am J Gastroenterol. 2008;103:27–37.
Mulder DJ, Justinich CJ. Understanding eosinophilic esophagitis: the cellular and molecular mechanisms of an emerging disease. Mucosal Immunol. 2011;4:139–147.
Whelan KA, Godwin BC, Wilkins B, et al. Persistent basal cell hyperplasia is associated with clinical and endoscopic findings in patients with histologically inactive eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2020;18:1475–1482 e1.
Hiestand M, Jalil AA, Castell DO. Manometric subtypes of ineffective esophageal motility. Clin Transl Gastroenterol. 2017;8:e78.
Zhang X, Geboes K, Depoortere I, et al. Effect of repeated cycles of acute esophagitis and healing on esophageal peristalsis, tone, and length. Am J Physiol Liver Physiol. 2005;288:G1339–G1346.
Rieder F, Cheng L, Harnett KM, et al. Gastroesophageal reflux disease–associated esophagitis induces endogenous cytokine production leading to motor abnormalities. Gastroenterology. 2007;132:154–165.
Zerbib F, Marin I, Cisternas D, et al. Ineffective esophageal motility and bolus clearance. A study with combined high‐resolution manometry and impedance in asymptomatic controls and patients. Neurogastroenterol Motil. 2020;32:1–8.
Gyawali CP, Zerbib F, Bhatia S, et al. Chicago Classification update (V4.0): technical review on diagnostic criteria for ineffective esophageal motility and absent contractility. Neurogastroenterol Motil. 2021;33:1–12.
Kovacs B. Clinical spectrum and presentation of patients with absent contractility. Ann Gastroenterol. 2021;34:331–336.
Spechler SJ, Konda V, Souza R. Can eosinophilic esophagitis cause achalasia and other esophageal motility disorders? Am J Gastroenterol. 2018;113:1594–1599.
Nelson M, Zhang X, Pan Z, et al. Mast cell effects on esophageal smooth muscle and their potential role in eosinophilic esophagitis and achalasia. Am J Physiol Liver Physiol. 2021;320:G319–G327.
Aceves SS, Ackerman SJ. Relationships between eosinophilic inflammation, tissue remodeling, and fibrosis in eosinophilic esophagitis. Immunol Allergy Clin North Am. 2009;29:197–211.
Aceves SS. Remodeling and fibrosis in chronic eosinophil inflammation. Dig Dis. 2014;32:15–21.
Kwiatek MA, Hirano I, Kahrilas PJ, et al. Mechanical properties of the esophagus in eosinophilic esophagitis. Gastroenterology. 2011;140:82–90.
Lin Z, Kahrilas PJ, Xiao Y, et al. Functional luminal imaging probe topography: an improved method for characterizing esophageal distensibility in eosinophilic esophagitis. Therap Adv Gastroenterol. 2013;6:97–107.
Carlson DA, Lin Z, Hirano I, et al. Evaluation of esophageal distensibility in eosinophilic esophagitis: an update and comparison of functional lumen imaging probe analytic methods. Neurogastroenterol Motil. 2016;28:1844–1853.
Hirano I, Moy N, Heckman MG, et al. Endoscopic assessment of the oesophageal features of eosinophilic oesophagitis: validation of a novel classification and grading system. Gut. 2013;62:489–495.
Dellon ES, Aderoju A, Woosley JT, et al. Variability in diagnostic criteria for eosinophilic esophagitis: a systematic review. Am J Gastroenterol. 2007;102:2300–2313.
Sanagapalli S, McGuire J, Leong RW, et al. The clinical relevance of manometric esophagogastric junction outflow obstruction can be determined using rapid drink challenge and solid swallows. Am J Gastroenterol. 2021;116:280–288.
Evrard S, Louis H, Kahaleh M, et al. Idiopathic eosinophilic oesophagitis: atypical presentation of a rare disease. Acta Gastroenterol Belg. 2004;67:232–235.
Stevoff C, Rao S, Parsons W, et al. EUS and histopathologic correlates in eosinophilic esophagitis. Gastrointest Endosc. 2001;54:373–377.
Tang Y, Xiong W, Yu T, et al. Eosinophilic esophageal myositis a plausible cause of histological changes of primary jackhammer esophagus: a case report. Am J Gastroenterol. 2018;113:150–152.
Takahashi K, Sato H, Tominaga K, et al. Gastrointestinal: a case of hypereosinophilic syndrome with esophageal involvement. J Gastroenterol Hepatol. 2018;33:1817–1817.
Aceves SS, Chen D, Newbury RO, et al. Mast cells infiltrate the esophageal smooth muscle in patients with eosinophilic esophagitis, express TGF-β1, and increase esophageal smooth muscle contraction. J Allergy Clin Immunol. 2010;126:1198–1204.e4.
Gentile N, Katzka D, Ravi K, et al. Oesophageal narrowing is common and frequently under-appreciated at endoscopy in patients with oesophageal eosinophilia. Aliment Pharmacol Ther. 2014;40:1333–1340.
Katzka DA. How do we assess what lies beneath in eosinophilic esophagitis. Gastrointest Endosc. 2018;87:969–971.
Carlson DA, Kou W, Lin Z, et al. Normal values of esophageal distensibility and distension-induced contractility measured by functional luminal imaging probe panometry. Clin Gastroenterol Hepatol. 2019;17:674–681.e1.
Sami SS, Haboubi HN, Ang Y, et al. UK guidelines on oesophageal dilatation in clinical practice. Gut. 2018;67:1000–1023.
Attwood S, Epstein J. Eosinophilic oesophagitis: recent advances and practical management. Frontline Gastroenterol. 2021;12:644–649.